Barclays upgraded the company's rating from Equal Weight to Overweight with a price target of $72, citing a potential turnaround after years of decline. The stock was also named one of the best stocks to buy by a major investment firm. Despite a significant multi-year share price pullback, recent broker upgrades and a focus on its underlying cash flow value suggest analysts see potential for recovery. The stock has shown recent positive momentum over 7-day and 30-day periods.